Latest
Stock Titan Regulatory and legal
GT Biopharma (NASDAQ: GTBP) wins approval for reverse split and share plan changes
GT Biopharma shareholders approved a reverse stock split, ranging from 1-for-10 to 1-for-30, and a reduction in authorized shares to 25,000,000 common and 1,500,000 preferred shares. They also approved a 3,500,000-share increase to the 2022 Omnibus Incentive Plan and an evergreen provision for automatic annual increases. These decisions were made at the Annual Meeting held on August 14, …
Main company
🇺🇸 United States
Read at Stock Titan